Biblio

Found 86 results
Filters: Keyword is Breast Neoplasms  [Clear All Filters]
2013
Marcus AC, Diefenbach MA, Stanton AL, Miller SM, Fleisher L, Raich PC, Morra ME, Perocchia RSlevin, Tran ZVu, Bright MAnne.  2013.  Cancer patient and survivor research from the cancer information service research consortium: a preview of three large randomized trials and initial lessons learned.. J Health Commun. 18(5):543-62.
Christie KM, Meyerowitz BE, Stanton AL, Rowland JH, Ganz PA.  2013.  Characteristics of breast cancer survivors that predict partners' participation in research.. Ann Behav Med. 46(1):107-13.
Ganz PA, Kwan L, Castellon SA, Oppenheim A, Bower JE, Silverman DHS, Cole SW, Irwin MR, Ancoli-Israel S, Belin TR.  2013.  Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.. J Natl Cancer Inst. 105(11):791-801.
Bower JE, Ganz PA, Irwin MR, Castellon S, Arevalo J, Cole SW.  2013.  Cytokine genetic variations and fatigue among patients with breast cancer.. J Clin Oncol. 31(13):1656-61.
Ganz PA, Bower JE, Kwan L, Castellon SA, Silverman DHS, Geist C, Breen EC, Irwin MR, Cole SW.  2013.  Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction? Brain Behav Immun. 30 Suppl:S99-108.
Campo RA, O'Connor K, Light KC, Nakamura Y, Lipschitz DL, LaStayo PC, Pappas L, Boucher K, Irwin MR, Agarwal N et al..  2013.  Feasibility and acceptability of a Tai Chi Chih randomized controlled trial in senior female cancer survivors.. Integr Cancer Ther. 12(6):464-74.
Kaminskas LM, Ascher DB, McLeod VM, Herold MJ, Le CP, Sloan EK, Porter CJH.  2013.  PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases.. J Control Release. 168(2):200-8.
Stanton AL, Thompson EH, Crespi CM, Link JS, Waisman JR.  2013.  Project connect online: randomized trial of an internet-based program to chronicle the cancer experience and facilitate communication.. J Clin Oncol. 31(27):3411-7.
Stanton AL, Morra ME, Diefenbach MA, Miller SM, Perocchia RSlevin, Raich PC, Fleisher L, Wen K-Y, Tran ZVu, Mohamed NE et al..  2013.  Responding to a significant recruitment challenge within three nationwide psychoeducational trials for cancer patients.. J Cancer Surviv. 7(3):392-403.
Thompson E, Stanton AL, Bower JE.  2013.  Situational and dispositional goal adjustment in the context of metastatic cancer.. J Pers. 81(5):441-51.
Sørensen GVrelits, Ganz PA, Cole SW, Pedersen LA, Sørensen HToft, Cronin-Fenton DP, Garne JPeter, Christiansen PM, Lash TL, Ahern TP.  2013.  Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.. J Clin Oncol. 31(18):2265-72.
2012
Yanez B, Stanton AL, Maly RC.  2012.  Breast cancer treatment decision making among Latinas and non-Latina Whites: a communication model predicting decisional outcomes and quality of life.. Health Psychol. 31(5):552-61.
Antoni MH, Lutgendorf SK, Blomberg B, Carver CS, Lechner S, Diaz A, Stagl J, Arevalo JMG, Cole SW.  2012.  Cognitive-behavioral stress management reverses anxiety-related leukocyte transcriptional dynamics.. Biol Psychiatry. 71(4):366-72.
Wen K-Y, Miller SM, Stanton AL, Fleisher L, Morra ME, Jorge A, Diefenbach MA, Ropka ME, Marcus AC.  2012.  The development and preliminary testing of a multimedia patient-provider survivorship communication module for breast cancer survivors.. Patient Educ Couns. 88(2):344-9.
Stanton AL, Low CA.  2012.  Dispositional and stressor-related emotion regulation in the context of a chronic, life-limiting stressor.. J Pers. 80(2):287-311.
Vodermaier A, Stanton AL.  2012.  Familial breast cancer: less emotional distress in adult daughters if they provide emotional support to their affected mother.. Fam Cancer. 11(4):645-52.
Algoe SB, Stanton AL.  2012.  Gratitude when it is needed most: social functions of gratitude in women with metastatic breast cancer.. Emotion. 12(1):163-8.
Howard-Anderson J, Ganz PA, Bower JE, Stanton AL.  2012.  Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review.. J Natl Cancer Inst. 104(5):386-405.
Bower JE.  2012.  Treating cancer-related fatigue: the search for interventions that target those most in need.. J Clin Oncol. 30(36):4449-50.
Bower JE, Garet D, Sternlieb B, Ganz PA, Irwin MR, Olmstead R, Greendale G.  2012.  Yoga for persistent fatigue in breast cancer survivors: a randomized controlled trial.. Cancer. 118(15):3766-75.
2011
Ganz PA, Habel LA, Weltzien EK, Caan BJ, Cole SW.  2011.  Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort.. Breast Cancer Res Treat. 129(2):549-56.
Ganz PA, Cole SW.  2011.  Expanding our therapeutic options: Beta blockers for breast cancer? J Clin Oncol. 29(19):2612-6.
Bower JE, Ganz PA, Irwin MR, Arevalo JMG, Cole SW.  2011.  Fatigue and gene expression in human leukocytes: increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue.. Brain Behav Immun. 25(1):147-50.
Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW.  2011.  Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol. 29(26):3517-22.
Kraemer LM, Stanton AL, Meyerowitz BE, Rowland JH, Ganz PA.  2011.  A longitudinal examination of couples' coping strategies as predictors of adjustment to breast cancer.. J Fam Psychol. 25(6):963-72.

Pages